Provided by Tiger Trade Technology Pte. Ltd.

CNBX Pharmaceuticals Inc.

0.0004
0.0000-11.11%
Volume:19.62M
Turnover:8.00K
Market Cap:221.60K
PE:-0.12
High:0.0005
Open:0.0004
Low:0.0004
Close:0.0005
52wk High:0.0157
52wk Low:0.0002
Shares:554.00M
Float Shares:91.79M
Volume Ratio:0.75
T/O Rate:21.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0035
EPS(LYR):-0.0035
ROE:-4289.36%
ROA:-681.68%
PB:-0.09
PE(LYR):-0.12

Loading ...

Dec 01, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 30, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 06, 2024

Correspondence

Form CORRESP - Correspondence
May 22, 2024

Correspondence

Form CORRESP - Correspondence
Apr 16, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 10, 2024

Correspondence

Form CORRESP - Correspondence
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 30, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 06, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Major Issues Report

8-K - Current report